APA (7th ed.) Citation

N, I., T, S., Y, I., H, A., T, N., T, T., & S, N. (2021). A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press.

Chicago Style (17th ed.) Citation

N, Ishii, Shimizu T, Ishiura Y, Amuro H, Nishizawa T, Tamaki T, and Nomura S. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.

MLA (8th ed.) Citation

N, Ishii, et al. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.